
2017 JP Morgan Healthcare Conference Recap
A Healthy Dose
00:00
Theranos aftermath and investor due diligence
Panel reflects on Theranos' impact, greater scrutiny, and the need for clinical evidence in health startups.
Play episode from 23:19
Transcript


